Macular Edema: all 847 studies
Page 5 of 9. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Use of Ziv Aflibercept in Different Retinal DiseasesCompletedNCT04290195Phase 1/2
- Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in TaiwanCompletedNCT04288232Phase 3
- Changes in Optical Coherence Tomography Leakage Mapping in Diabetic Macular Edema After Conbercept TreatmentStatus unknownNCT04254536
- Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow LaserCompletedNCT04234438Not applicable
- New Concepts in Diabetic Macular Edema (DME)CompletedNCT04186702Not applicable
- Incidence of Sub-clinical Cystoid Macular Edema After Cataract SurgeryStatus unknownNCT04161963
- The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)Status unknownNCT04151407Phase 1
- Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug InjectionsStatus unknownNCT04142164Not applicable
- Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical PracticeCompletedNCT04137120
- High Resolution Retina ImagingStatus unknownNCT04128150
- Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior PoleActive, not recruitingNCT04120636Phase 1
- Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior PoleActive, not recruitingNCT04120311Phase 1
- Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal BevacizumabCompletedNCT04119921Phase 2/3
- Influence of Cataract Surgery on Early DME The DICAT-II StudyCompletedNCT04096131
- Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular EdemaCompletedNCT04089605Phase 4
- Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME)CompletedNCT04087746Phase 4
- Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaWithdrawnNCT04079231Phase 3
- Suprachoroidal Injection of Triamcinolone Acetonide for Management of Diabetic Macular EdemaStatus unknownNCT04069780Not applicable
- Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract SurgeryWithdrawnNCT04067856Not applicable
- Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract SurgeryStatus unknownNCT04063358Phase 3
- Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein OcclusionStatus unknownNCT04062370Phase 4
- Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DMEStatus unknownNCT04038125Phase 4
- Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study)CompletedNCT04018482Phase 4
- Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular EdemaCompletedNCT04014556Not applicable
- A Phase I Study of Episcleral Dexamethasone for Treatment of Macular EdemaActive, not recruitingNCT04005430Phase 1
- Anti-VEGF Therapy Versus Dexamethasone Implant for DMEStatus unknownNCT03999125Phase 4
- One Year Trial Evaluating Safety of Ozurdex With EyleaCompletedNCT03984110Phase 4
- Sub-macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular EdemaCompletedNCT03975088Not applicable
- One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to BevacizumabCompletedNCT03974425Not applicable
- Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With RanibizumabStatus unknownNCT03973138Phase 1/2
- NOTAL-OCT V.2.5 vs Commercial OCT in AMD PatientsCompletedNCT03969303
- Epiretinal Membrane and Cystoid Macular Oedema Post-cataract SurgeryCompletedNCT03965078
- Long Term Safety of Cooling Anesthesia for Intravitreal InjectionCompletedNCT03956797Not applicable
- A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never TreatedCompletedNCT03953807Phase 4
- Effect of Dexamethasone Implant on Optic DiscCompletedNCT03927118
- Cataract DME - Peri vs. IntraopWithdrawnNCT03920878Phase 2
- Post Intravitreal Injection Topical NSAID vs. PatchingStatus unknownNCT03918590Phase 4
- Treatment of Macular Edema Caused by Leber's Miliary Aneurysms Using Intravitreal Aflibercept and Peripheral Laser PhotocoagulationStatus unknownNCT03908723Not applicable
- Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in ChinaCompletedNCT03908307Phase 4
- Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVOStatus unknownNCT03892434Phase 4
- Aflibercept With and Without Micropulse Laser in Diabetic Macular EdemaCompletedNCT03866746Phase 4
- Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular EdemaStatus unknownNCT03866005Not applicable
- Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease PreventionStatus unknownNCT03859245Not applicable
- A Study Assessing AR-13503 Implant in Subjects With nAMD or DMECompletedNCT03835884Phase 1
- The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular EdemaStatus unknownNCT03821168Phase 2/3
- Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVOTerminatedNCT03790852Phase 1
- Combined Ranibizumab and Iluvien for Diabetic Macular OedemaWithdrawnNCT03784443Phase 2/3
- Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-AngiographyStatus unknownNCT03783832
- Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)CompletedNCT03780361Phase 4
- Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA StudyStatus unknownNCT03762226
- Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular EdemaStatus unknownNCT03759860Phase 4
- Ocular Manifestations in Rheumatic DiseasesCompletedNCT03753893
- Targeted Laser in Diabetic Macular EdemaCompletedNCT03751501Not applicable
- Cooling Anesthesia for Intravitreal InjectionCompletedNCT03732287Phase 1/2
- Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DMECompletedNCT03690947Phase 4
- A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema.CompletedNCT03690050Not applicable
- A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)CompletedNCT03666923Phase 1
- Shanghai Cohort Study of Diabetic Eye DiseaseStatus unknownNCT03665090
- ILM Peeling in PDR Patients Undergoing PPV for VHCompletedNCT03660371Not applicable
- PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DMECompletedNCT03660345Phase 3
- Navigated Laser In Branch Retinal Vein Occlusion StudyCompletedNCT03651011Not applicable
- Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular EdemaStatus unknownNCT03641144Not applicable
- The Study to YD312 Tablet in Patients With Diabetic Macular EdemaStatus unknownNCT03635814Phase 2
- Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular EdemaWithdrawnNCT03629210Phase 2
- Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal DisordersStatus unknownNCT03606733Not applicable
- Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular EdemaWithdrawnNCT03603990Not applicable
- Curcumin and Intravitreal Dexamethasone in Diabetic Macular EdemaCompletedNCT03598205Not applicable
- Diabetic Macular Edema - Obstructive Sleep Apnea Relationship StudyStatus unknownNCT03597815
- Rapid Structural and Functional Improvements in Following 0.19 mg Fluocinolone Acetonide (FAc) Implant in Diabetic Macular Edema Patients With Poor Visual Acuity: 12-month Audit Results From United Arab EmiratesStatus unknownNCT03590587
- Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal LaserCompletedNCT03590444Phase 4
- Multimodal Image Study of Retinal Inflammation Markers After Corticoid and Antiangiogenic Treatment in Pacients With Diabetic Macular EdemaStatus unknownNCT03583242
- Dexamethasone Intravitreal Implant in Retinal Vein OcclusionCompletedNCT03559491
- Prophylactic Effect of Ketorolac Tromethamine on the Cystoid Macular Edema After Phacoemulsification in Diabetic PatientsStatus unknownNCT03551808Phase 2
- Alzer® and Diamel® to Prevent Severe Diabetes Macular EdemaCompletedNCT03533478Phase 2
- A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)CompletedNCT03511898Phase 1
- A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME)CompletedNCT03499223Phase 2
- To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes MellitusCompletedNCT03495765Phase 3
- Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic RetinopathyCompletedNCT03490318
- Correlation Between the Visual Acuity & the OCT Pattern of Macular Edema Secondary to RVOStatus unknownNCT03489915
- The Effects of Intravitreal Ozurdex Implant in DMEStatus unknownNCT03475407Phase 4
- A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin AmericaCompletedNCT03470103
- Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract SurgeryStatus unknownNCT03465124Not applicable
- Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.Status unknownNCT03458923Phase 4
- Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept InjectionCompletedNCT03453281Phase 4
- Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein OcclusionStatus unknownNCT03405376Phase 4
- "Cataract Surgery in Eyes With Epiretinal Membrane"CompletedNCT03404323
- Treatment of Macular Edema After Cataract Surgery with Subconjunctival AfliberceptTerminatedNCT03396861Phase 1
- Comparison of VA Guided Versus OCT Guided TER Using Aflibercept for Diabetic Macular Edema (AVOCT Study)TerminatedNCT03394573
- Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated PatientsStatus unknownNCT03391219Phase 2/3
- Ranibizumab Versus Dexamethasone Implant in Diabetic Macular EdemaCompletedNCT03385382
- The Results of Pars Plana Vitrectomy in Diabetic Macular EdemaStatus unknownNCT03384901
- Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DMEWithdrawnNCT03384524Phase 1/2
- Study for Optimizing Anti-inflammatory ProphylaxisCompletedNCT03383328Phase 4
- Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3CompletedNCT03355638Phase 4
- Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein OcclusionStatus unknownNCT03353324Phase 2/3
- iOCT for Patients With Diabetic Macular EdemaCompletedNCT03328715Not applicable
- Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept InjectionStatus unknownNCT03297684
- RCT to Investigate if Prostaglandin Analogue Drops Increase the Risk of Cystoid Macular Oedema After Cataract Surgery.CompletedNCT03292796Phase 2
- Usability and Ergonomic Evaluation of Self-Positioning System for Retinal ImagingCompletedNCT03270865Not applicable
- Ranibizumab Plus IndomethacinCompletedNCT03261635Phase 4